ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014

Funding Opportunities.

April 12, 2002

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

January 11, 2013

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984